Oral cancers are associated with inflammatory mediators, such as IL-6 and TNF, which potentially exert their effects through dual mechanisms, namely, by enhancing the extravasation of albumin across the capillary endothelium at the tumor site and dampening the hepatic production of albumin. Here, IL6 is linked to lip and oral cavity carcinoma.